Genetic Polymorphism of Interleukin-6 in Asymptomatic and ICU-Admitted COVID-19 Patients in Sulaymaniyah Province, Kurdistan Region of Iraq

• Published in: Genetic testing and molecular biomarkers Vol. 28; no. 7; p. 297
• Main Authors: Rashid, Peshnyar M A, Salih, Gaza F
• Format: Journal Article
• Language: English
• Published: United States 01.07.2024
• Subjects: Adult; Alleles; COVID-19 - genetics; Female; Gene Frequency - genetics; Genetic Predisposition to Disease; Genotype; Haplotypes - genetics; Humans; Intensive Care Units; Interleukin-6 - genetics; Iraq; Male; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic - genetics; SARS-CoV-2; Iraq; COVID-19; cytokine; IL6; SARS-CoV-2; ICU
• ISSN: 1945-0257
• DOI: 10.1089/gtmb.2023.0304

The global pandemic of Coronavirus Disease 2019 (COVID-19) has resulted in significant fatality rates. Clinical outcomes for affected individuals range from being asymptomatic to severe illnesses requiring intensive care unit (ICU) admission. Among the various factors contributing to the variation in clinical outcomes, host genetics play a prominent role. Interleukin-6 (IL6), a key player in immune responses, has been identified as having a crucial impact on viral infections, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Specifically, certain variations known as single nucleotide polymorphisms (SNPs) in the IL6 promoter region have been found to significantly influence IL6 expression and the severity of viral infections. To explore the relationship between these genetic variations and COVID-19 in asymptomatic and ICU-admitted Kurdish patients, genetic sequencing was performed to determine the genotypes of nine IL6 SNPs. The study findings revealed that although the proportion of the GG genotype of rs1800795 was slightly higher in asymptomatic COVID-19 cases, the difference was not statistically significant (chi2 = 2.666, = 0.236). Notably, Kurdish patients displayed a uniform genetic makeup (monomorphic) for the dominant alleles of rs2069830 (C), rs142759801 (C), rs2069857 (C), rs2069829 (G), rs2234683 (G), rs13447446 (T), rs527770772 (C), and rs13447445 (C). Furthermore, patients carrying the haplotype GCGGCTCCC were found to have a 0.481-fold higher likelihood of being asymptomatic with COVID-19 ( = 0.016, OR = 0.481). This study demonstrates that the rs1800795 SNP is not statistically associated with COVID-19 at the genotype level. However, the presence of the dominant G allele of rs1800795 in the haplotype was found to be statistically associated with asymptomatic COVID-19 patients.